Tenecteplase: More Evidence It Should Replace Alteplase for Ischemic Stroke Treatment.
作者信息
Kreitzer Natalie
机构信息
Department of Emergency Medicine, University of Cincinnati, Cincinnati, OH.
出版信息
Ann Emerg Med. 2023 Dec;82(6):729-731. doi: 10.1016/j.annemergmed.2023.07.016. Epub 2023 Aug 18.
Abstract
摘要
相似文献
1
Tenecteplase: More Evidence It Should Replace Alteplase for Ischemic Stroke Treatment.替奈普酶：更多证据表明其应取代阿替普酶用于缺血性中风治疗。
Ann Emerg Med. 2023 Dec;82(6):729-731. doi: 10.1016/j.annemergmed.2023.07.016. Epub 2023 Aug 18.
2
Tenecteplase to Replace Alteplase? Comparing Thrombolytic Therapies for Acute Ischemic Stroke: June 2023 Annals of Emergency Medicine Journal Club.替奈普酶能否取代阿替普酶？急性缺血性卒中溶栓治疗的比较：2023年6月《急诊医学年鉴》期刊俱乐部
Ann Emerg Med. 2023 Jun;81(6):759-760. doi: 10.1016/j.annemergmed.2023.04.012.
3
Tenecteplase versus alteplase for early treatment of ischaemic stroke - Authors' reply.替奈普酶与阿替普酶用于缺血性卒中的早期治疗——作者回复
Lancet Neurol. 2022 Nov;21(11):959. doi: 10.1016/S1474-4422(22)00358-1.
4
Evolving Thrombolytics: from Alteplase to Tenecteplase.不断发展的溶栓药物：从阿替普酶到替奈普酶。
Neurotherapeutics. 2023 Apr;20(3):664-678. doi: 10.1007/s13311-023-01391-3. Epub 2023 Jun 5.
5
Implementation of Tenecteplase for Acute Ischemic Stroke Treatment.替奈普酶在急性缺血性卒中治疗中的应用
J Emerg Nurs. 2024 Mar;50(2):171-177. doi: 10.1016/j.jen.2023.11.004. Epub 2023 Dec 7.
6
Intravenous tenecteplase compared with alteplase for acute ischemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.加拿大急性缺血性卒中静脉注射替奈普酶与阿替普酶对比研究（AcT）：一项实用、多中心、开放标签、与注册登记相关的随机对照非劣效性试验。
CJEM. 2023 Feb;25(2):121-122. doi: 10.1007/s43678-022-00432-8. Epub 2022 Dec 29.
7
Tenecteplase for acute ischaemic stroke.替奈普酶用于急性缺血性脑卒中
Lancet. 2022 Jul 16;400(10347):138-139. doi: 10.1016/S0140-6736(22)01107-2. Epub 2022 Jun 29.
8
IV tenecteplase: A non-inferior alternative to alteplase?IV 替奈普酶：阿替普酶的非劣效替代选择？
Med. 2022 Aug 12;3(8):519-520. doi: 10.1016/j.medj.2022.07.006.
9
Tranexamic acid for treatment of symptomatic hemorrhagic conversion following administration of tenecteplase for acute ischemic stroke.氨甲环酸用于治疗替奈普酶治疗急性缺血性卒中后有症状的出血性转化。
Am J Emerg Med. 2022 Sep;59:216.e1-216.e5. doi: 10.1016/j.ajem.2022.06.022. Epub 2022 Jun 12.
10
Freezing Tenecteplase Into Aliquots to Reduce Waste in Acute Ischemic Stroke.将替奈普酶分装冷冻以减少急性缺血性卒中治疗中的浪费
Stroke. 2024 Jan;55(1):e1-e2. doi: 10.1161/STROKEAHA.123.044345. Epub 2023 Dec 8.
引用本文的文献
1
A Transfer Strategy Utilizing a Helicopter and a Ground Ambulance Together Does Not Prolong Door-In-Door-Out Times in Thrombectomy Patients: A Retrospective Analysis.直升机与地面救护车联合转运策略不会延长血栓切除术患者的门到门时间：一项回顾性分析
Eur J Neurol. 2025 Jun;32(6):e70148. doi: 10.1111/ene.70148.
本文引用的文献
1
Trial of Endovascular Thrombectomy for Large Ischemic Strokes.大型缺血性卒中血管内血栓切除术试验
N Engl J Med. 2023 Apr 6;388(14):1259-1271. doi: 10.1056/NEJMoa2214403. Epub 2023 Feb 10.
2
Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct.大面积梗死急性缺血性卒中血管内治疗试验
N Engl J Med. 2023 Apr 6;388(14):1272-1283. doi: 10.1056/NEJMoa2213379. Epub 2023 Feb 10.
3
Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial.非对比 CT 评估的觉醒型卒中患者使用替奈普酶的安全性和有效性（TWIST）：一项多中心、开放标签、随机对照试验。
Lancet Neurol. 2023 Feb;22(2):117-126. doi: 10.1016/S1474-4422(22)00484-7. Epub 2022 Dec 19.
4
Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.加拿大急性缺血性脑卒中静脉内替奈普酶与阿替普酶比较（AcT）：一项实用的、多中心、开放标签、与登记系统相关联、随机化、对照、非劣效性试验。
Lancet. 2022 Jul 16;400(10347):161-169. doi: 10.1016/S0140-6736(22)01054-6. Epub 2022 Jun 29.
5
Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial.替奈普酶与阿替普酶治疗挪威急性缺血性卒中（NOR-TEST 2，A部分）：一项3期随机开放标签盲终点非劣效性试验
Lancet Neurol. 2022 Jun;21(6):511-519. doi: 10.1016/S1474-4422(22)00124-7. Epub 2022 May 4.
6
Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study.替奈普酶与阿替普酶治疗急性缺血性脑卒中患者的安全性和有效性（TRACE）：一项多中心、随机、开放标签、盲终点（PROBE）对照的 II 期研究。
Stroke Vasc Neurol. 2022 Feb;7(1):47-53. doi: 10.1136/svn-2021-000978. Epub 2021 Aug 24.
7
Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke: The EXTEND-IA TNK Part 2 Randomized Clinical Trial.静脉注射替奈普酶剂量对大血管闭塞性缺血性脑卒中患者取栓前脑再灌注的影响：EXTEND-IA TNK 第 2 部分随机临床试验。
JAMA. 2020 Apr 7;323(13):1257-1265. doi: 10.1001/jama.2020.1511.
8
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset.MRI 引导下的不明时间起病脑卒中溶栓治疗。
N Engl J Med. 2018 Aug 16;379(7):611-622. doi: 10.1056/NEJMoa1804355. Epub 2018 May 16.
9
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct.发病后 6 至 24 小时内进行取栓术治疗与缺损和梗死不匹配的脑卒中。
N Engl J Med. 2018 Jan 4;378(1):11-21. doi: 10.1056/NEJMoa1706442. Epub 2017 Nov 11.
10
A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3).多中心随机对照试验的血管内治疗后的影像学评估缺血性脑卒中（DEFUSE 3）。
Int J Stroke. 2017 Oct;12(8):896-905. doi: 10.1177/1747493017701147. Epub 2017 Mar 24.
Zotero 插件